Please login to the form below

Not currently logged in
Email:
Password:

Bain Capital

This page shows the latest Bain Capital news and features for those working in and with pharma, biotech and healthcare.

Pfizer spins out SpringWorks Therapeutics biotech

Pfizer spins out SpringWorks Therapeutics biotech

funding from the drugmaker plus venture capitalists Bain Capital and Orbimed and medical charity LifeArc. ... Pfizer is contributing both equity capital and royalty- and milestone-bearing licenses to the experimental therapies.

Latest news

  • No deal for Stada as private equity takeover bid collapses No deal for Stada as private equity takeover bid collapses

    Bain Capital and Cinven's planned buyout of Germany's Stada has failed at the last hurdle, with too few of Stada's shareholders agreeing to the deal by the deadline. ... Stada's board had lent its support to the Bain-Cinven offer over a rival 58 per

  • Private equity firms agree deal to take over Stada Private equity firms agree deal to take over Stada

    Private equity firms agree deal to take over Stada. Cinven and Bain Capital beat out competition from Advent International. ... Cinven and Bain Capital made what Stada said was the "most financially appealing offer" of 66 per share, topping an earlier

  • Stada opens books to let formal bidding commence Stada opens books to let formal bidding commence

    Stada opens books to let formal bidding commence. Cinven, Advent International and Bain Capital now have opportunity to revise their bids. ... The three interested parties - confirmed as Cinven, Advent International and Bain Capital - will now all

  • Advent tops Cinven offer for Stada as third suitor looms Advent tops Cinven offer for Stada as third suitor looms

    It has also emerged that the two-horse race has attracted another runner, with a third, non-binding offer from an unnamed company - rumoured to be Bain Capital - matching Advent's ... For months, Stada has been under pressure from rebel investor Active

  • Stada confirms Cinven as one of two takeover bidders Stada confirms Cinven as one of two takeover bidders

    Other private equity groups, including Advent, Bain Capital, CVC Capital Partners and Permira, have also been rumoured to have an interest in buying the German company, while Polish generic drug company ... The rebel investors - led by Active Ownership

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Innocoll (pharma). 209. Capital International. Minority share. Intas (pharma). 106. Bain and others. ... 4, 750 (incl. debt). Stada (DE). Bain Capital and Cinven. Company acquisition.

  • Deal Watch February 2017 Deal Watch February 2017

    A third suitor is believed to be another PE firm, Bain Capital.

  • Deal Watch February 2016 Deal Watch February 2016

    A couple of weeks later Stryker paid $1.28bn (approximately 2.5 x sales) to buy Physio-Control from Bain Capital. ... Founded in the 1950s, Physio-Control is a pioneer of defibrillator/monitor technologies and was owned by Lilly and then Medtronic before

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics